A comparative multi-centre study of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV)
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in Phytomedicine
- Vol. 7 (1), 1-6
- https://doi.org/10.1016/s0944-7113(00)80014-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Genital herpes—how much of a public-health problem?The Lancet, 1998
- Decline of Herpes Simplex Virus Type 2 and Chlamydia trachomatis Infections from 1970 to 1993 Indicated by a Similar Change in Antibody PatternScandinavian Journal of Infectious Diseases, 1995
- Comparison of the Anti-Herpes Simplex Virus Activities of Propolis and 3-Methyl-but-2-enyl CaffeateJournal of Natural Products, 1994
- Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study GroupArchives of Dermatology, 1993
- Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. The Acyclovir Study GroupPublished by American Medical Association (AMA) ,1991
- Topical treatment of cutaneous herpes simplex virus infectionsAntiviral Research, 1990
- A Seroepidemiologic Survey of the Prevalence of Herpes Simplex Virus Type 2 Infection in the United StatesNew England Journal of Medicine, 1989
- Detection of Herpes Simplex Virus in Women with Acute Pelvic Inflammatory DiseaseThe Journal of Infectious Diseases, 1985
- Herpes Simplex Chorioretinitis in a Healthy AdultAmerican Journal of Ophthalmology, 1983
- Successful treatment of herpes labialis with topical acyclovir.BMJ, 1983